Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Oct 4, 2018
Open Peer Review Period: Oct 5, 2018 - Nov 12, 2018
Date Accepted: Jan 14, 2019
(closed for review but you can still tweet)
Effective engagement of adolescent asthma patients with mHealth supporting medication adherence
ABSTRACT
Background:
Mobile health (mHealth) applications have the potential to support patient’s medication use and are therefore increasingly used. Applications with broad functionality are suggested to be more effective, however not much is known about the actual use of different functionalities.
Objective:
The aim of this study was to describe the use of the ADolescent Adherence Patient Tool (ADAPT), a mHealth application with several functionalities, by adolescent asthma patients (age 12-18 years).
Methods:
Data of the ADAPT study, a cluster randomized controlled trial, was used. Patients in the intervention group had six months access to the ADAPT intervention, which consisted of an application (app) for patients and a management system for their pharmacists. The ADAPT app contained questionnaires to monitor symptoms and adherence, a medication reminder, short movies, a pharmacist chat, and a peer chat. All app use was securely registered in a log file.
Results:
In total, 86 adolescents (age 15.0±2.0 years) used the ADAPT app for 17 times (range 1-113) per person. Females used the app more often than males (P = .01). On average three different functionalities were used, and the questionnaires to monitor symptoms and adherence were mostly used. The total app use did not affect adherence, however activity in the pharmacist chat positively affected medication adherence (P = .03), in particular if patients sent messages to their pharmacist (P = .01).
Conclusions:
The ADAPT app is differently used by adolescents with asthma suggesting that mHealth applications should contain different functionalities in order to serve the diverging needs and preferences of individual patients. Clinical Trial: Dutch Trial Register; NTR5061; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5061
Citation
Per the author's request the PDF is not available.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.